ASPEN PHARMACARE HLDGS LTD ADR's ticker is APNHY and the CUSIP is 04530Y106. A total of 5 filers reported holding ASPEN PHARMACARE HLDGS LTD ADR in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $109,000 | +17.2% | 10,970 | -0.3% | 0.00% | – |
| Q4 2020 | $93,000 | +12.0% | 11,005 | -5.6% | 0.00% | – |
| Q3 2020 | $83,000 | -16.2% | 11,664 | -3.7% | 0.00% | – |
| Q2 2020 | $99,000 | -48.4% | 12,115 | -67.4% | 0.00% | – |
| Q1 2020 | $192,000 | -42.3% | 37,112 | -7.2% | 0.00% | – |
| Q4 2019 | $333,000 | +46.1% | 40,003 | -0.2% | 0.00% | – |
| Q3 2019 | $228,000 | -47.8% | 40,085 | -35.0% | 0.00% | – |
| Q2 2019 | $437,000 | -15.0% | 61,669 | -23.1% | 0.00% | – |
| Q1 2019 | $514,000 | -34.5% | 80,142 | -4.3% | 0.00% | -100.0% |
| Q4 2018 | $785,000 | -34.1% | 83,744 | -15.6% | 0.00% | 0.0% |
| Q3 2018 | $1,191,000 | -44.5% | 99,273 | -14.1% | 0.00% | -50.0% |
| Q2 2018 | $2,147,000 | -30.3% | 115,635 | -17.4% | 0.00% | -33.3% |
| Q1 2018 | $3,079,000 | +27.2% | 139,943 | +27.1% | 0.00% | +50.0% |
| Q4 2017 | $2,420,000 | +1.9% | 110,072 | +5.0% | 0.00% | -33.3% |
| Q3 2017 | $2,376,000 | +25.4% | 104,823 | +21.7% | 0.00% | +50.0% |
| Q2 2017 | $1,894,000 | +15.4% | 86,147 | +6.7% | 0.00% | -33.3% |
| Q1 2017 | $1,641,000 | +88.2% | 80,729 | +87.8% | 0.00% | +200.0% |
| Q4 2016 | $872,000 | – | 42,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QUADRANT CAPITAL GROUP LLC | 1,860 | $36,000 | 0.02% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 86,147 | $1,894,000 | 0.00% |
| Fisher Asset Management, LLC | 16,593 | $364,000 | 0.00% |
| GLENMEDE TRUST CO NA | 234 | $4,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 9,061 | $199,000 | 0.00% |